Published in J Immunol Res on October 28, 2015
Dendritic cells and the control of immunity. Nature (1998) 56.54
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
Taking dendritic cells into medicine. Nature (2007) 11.82
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer (2006) 7.53
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature (1997) 6.53
Structure and signalling in the IL-17 receptor family. Nat Rev Immunol (2009) 6.38
A cytoplasmic inhibitor of the JNK signal transduction pathway. Science (1997) 4.56
Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer (2006) 3.72
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol (1992) 3.63
Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med (2003) 3.21
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients. J Immunol (2009) 2.12
Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites. J Biol Chem (1995) 2.08
Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood (2001) 2.01
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol (1994) 1.97
Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J (2012) 1.89
Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol (2002) 1.88
The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem (1998) 1.86
Cytokines in breast cancer. Cytokine Growth Factor Rev (2006) 1.70
The IRF family, revisited. Biochimie (2007) 1.64
Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood (2000) 1.60
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. J Immunol (2007) 1.57
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res (2008) 1.53
Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev (2002) 1.50
The toxicology of interleukin-12: a review. Toxicol Pathol (1999) 1.23
Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12. Cancer Res (2008) 1.16
Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer. Clin Cancer Res (2010) 1.14
LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J Biol Chem (2002) 1.10
U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways. Cancer Res (2000) 1.09
Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo. Cancer Res (2005) 1.06
Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol (2003) 1.06
Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene (2004) 0.99
Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL. Curr Neurovasc Res (2012) 0.95
Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation. Int J Cancer (2008) 0.92
Activation of myelin genes during transdifferentiation from melanoma to glial cell phenotype. J Biol Chem (2003) 0.92
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. Cancer Immunol Immunother (2004) 0.89
Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function. Front Immunol (2013) 0.85
Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12. Eur J Clin Invest (2005) 0.83
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function. Blood (2012) 0.83
Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy. Crit Rev Immunol (2007) 0.83
SPARC/osteonectin is involved in metastatic process to the lung during melanoma progression. Virchows Arch (2014) 0.82
Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines. Head Neck (2010) 0.81
Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells. Dev Biol (Basel) (2004) 0.80
Tumor-dendritic cell fusion as a basis for cancer immunotherapy. Otolaryngol Head Neck Surg (2005) 0.80
Gadd45 proteins in immunity. Adv Exp Med Biol (2013) 0.80
Molecular functions of NEDD4 E3 ubiquitin ligases in cancer. Biochim Biophys Acta (2015) 0.79
Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination. J Surg Res (2013) 0.77
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity. Blood (2007) 1.05
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function. Blood (2012) 0.83
Oncolytic viruses in melanoma. Front Biosci (Landmark Ed) (2022) 0.75